$SNTA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MADRIGAL PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MADRIGAL PHARMACEUTICALS, INC.. Get notifications about new insider transactions in MADRIGAL PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 15 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Sell | S | 0.32 | 300,000 | 96,690 | 1,539,169 | 1.8 M to 1.5 M (-16.31 %) |
Dec 15 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Sell | S | 0.37 | 300,000 | 111,030 | 1,839,169 | 2.1 M to 1.8 M (-14.02 %) |
Dec 09 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Sell | S | 0.38 | 145,892 | 55,235 | 2,139,169 | 2.3 M to 2.1 M (-6.38 %) |
Dec 09 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Sell | S | 0.38 | 300,000 | 114,060 | 2,285,061 | 2.6 M to 2.3 M (-11.61 %) |
Dec 09 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Sell | S | 0.39 | 300,000 | 115,830 | 2,585,061 | 2.9 M to 2.6 M (-10.40 %) |
Dec 08 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.37 | 496,015 | 183,526 | 340,970 | 837 K to 341 K (-59.26 %) |
Dec 08 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.37 | 873,624 | 323,241 | 600,548 | 1.5 M to 600.5 K (-59.26 %) |
Dec 08 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.41 | 36 | 15 | 836,985 | 837 K to 837 K (0.00 %) |
Dec 08 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.41 | 64 | 26 | 1,474,172 | 1.5 M to 1.5 M (0.00 %) |
Dec 08 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.41 | 55,629 | 22,941 | 837,021 | 892.7 K to 837 K (-6.23 %) |
Dec 08 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.41 | 97,978 | 40,406 | 1,474,236 | 1.6 M to 1.5 M (-6.23 %) |
Dec 03 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.41 | 95,040 | 39,337 | 892,650 | 987.7 K to 892.7 K (-9.62 %) |
Dec 03 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.41 | 167,394 | 69,284 | 1,572,214 | 1.7 M to 1.6 M (-9.62 %) |
Dec 03 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.43 | 249,015 | 106,379 | 987,690 | 1.2 M to 987.7 K (-20.14 %) |
Dec 03 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.43 | 438,588 | 187,365 | 1,739,608 | 2.2 M to 1.7 M (-20.14 %) |
Dec 03 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.43 | 174,091 | 74,894 | 1,236,705 | 1.4 M to 1.2 M (-12.34 %) |
Dec 03 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.43 | 306,625 | 131,910 | 2,178,196 | 2.5 M to 2.2 M (-12.34 %) |
Nov 30 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.43 | 231,959 | 100,554 | 1,410,796 | 1.6 M to 1.4 M (-14.12 %) |
Nov 30 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.43 | 408,546 | 177,105 | 2,484,821 | 2.9 M to 2.5 M (-14.12 %) |
Nov 30 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.50 | 338,463 | 167,539 | 1,642,755 | 2 M to 1.6 M (-17.08 %) |
Nov 30 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.50 | 596,132 | 295,085 | 2,893,367 | 3.5 M to 2.9 M (-17.08 %) |
Nov 30 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.49 | 544,571 | 265,805 | 1,981,218 | 2.5 M to 2 M (-21.56 %) |
Nov 30 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.49 | 959,149 | 468,161 | 3,489,499 | 4.4 M to 3.5 M (-21.56 %) |
Nov 24 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.44 | 194,883 | 86,002 | 2,525,789 | 2.7 M to 2.5 M (-7.16 %) |
Nov 24 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.44 | 343,246 | 151,474 | 4,448,648 | 4.8 M to 4.4 M (-7.16 %) |
Nov 24 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.44 | 230,129 | 100,543 | 2,720,672 | 3 M to 2.7 M (-7.80 %) |
Nov 24 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.44 | 405,324 | 177,086 | 4,791,894 | 5.2 M to 4.8 M (-7.80 %) |
Nov 20 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.44 | 83,397 | 36,953 | 2,950,801 | 3 M to 3 M (-2.75 %) |
Nov 20 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.44 | 146,886 | 65,085 | 5,197,218 | 5.3 M to 5.2 M (-2.75 %) |
Nov 20 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.46 | 65,802 | 30,381 | 3,034,198 | 3.1 M to 3 M (-2.12 %) |
Nov 20 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.46 | 115,896 | 53,509 | 5,344,104 | 5.5 M to 5.3 M (-2.12 %) |
Nov 20 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.51 | 992,953 | 501,441 | 0 | 993 K to 0 (-100.00 %) |
Nov 20 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.43 | 108,154 | 46,820 | 992,953 | 1.1 M to 993 K (-9.82 %) |
Nov 19 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Sell | S | 0.41 | 100,000 | 41,400 | 2,885,061 | 3 M to 2.9 M (-3.35 %) |
Nov 17 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.42 | 700,618 | 295,661 | 1,101,107 | 1.8 M to 1.1 M (-38.89 %) |
Nov 17 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.44 | 15,530 | 6,759 | 1,801,725 | 1.8 M to 1.8 M (-0.85 %) |
Nov 17 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.43 | 507,788 | 219,568 | 1,817,255 | 2.3 M to 1.8 M (-21.84 %) |
Nov 12 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Buy | S | 0.55 | 188,322 | 103,050 | 2,985,061 | 2.8 M to 3 M (+6.73 %) |
Nov 12 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.47 | 733,564 | 347,783 | 2,325,043 | 3.1 M to 2.3 M (-23.98 %) |
Nov 12 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.50 | 1,080,941 | 538,201 | 3,058,607 | 4.1 M to 3.1 M (-26.11 %) |
Nov 12 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.55 | 1,397,114 | 769,111 | 4,139,548 | 5.5 M to 4.1 M (-25.23 %) |
Nov 12 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | S | 0.61 | 2,225,054 | 1,354,168 | 5,536,662 | 7.8 M to 5.5 M (-28.67 %) |
Nov 05 2015 | SNTA | SYNTA PHARMACEUTIC ... | Morenstein Scott D | Director | Option Exercise | A | 0.67 | 40,000 | 26,800 | 40,000 | |
Oct 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | SVP, Gen. Counsel | Option Exercise | A | 1.76 | 250,000 | 440,000 | 250,000 | |
Oct 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Vukovic Vojo | SVP, Chief Medical ... | Option Exercise | A | 1.76 | 132,300 | 232,848 | 132,300 | |
Oct 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Schneebaum Marc R | SVP and CFO | Option Exercise | A | 1.76 | 153,100 | 269,456 | 153,100 | |
Oct 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Schor Chen | President and CEO | Option Exercise | A | 1.76 | 250,000 | 440,000 | 250,000 | |
Oct 02 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | J | 0.00 | 4,000,000 | 0 | 11,399,464 | 15.4 M to 11.4 M (-25.97 %) |
Oct 02 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Buy | J | 0.00 | 4,000,000 | 0 | 4,000,000 | 0 to 4 M |
Oct 02 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | J | 0.00 | 120,854 | 0 | 0 | 120.9 K to 0 (-100.00 %) |
Oct 02 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Buy | J | 0.00 | 120,854 | 0 | 15,399,464 | 15.3 M to 15.4 M (+0.79 %) |
Sep 18 2015 | SNTA | SYNTA PHARMACEUTIC ... | Schor Chen | President and CEO | Option Exercise | A | 2.02 | 500,000 | 1,010,000 | 500,000 | |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | KUFE DONALD W | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 20,000 | |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Option Exercise | A | 2.20 | 15,000 | 33,000 | 15,000 | |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 20,000 | |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 4,545 | 0 | 401,764 | 397.2 K to 401.8 K (+1.14 %) |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 4,545 | 0 | 397,219 | 392.7 K to 397.2 K (+1.16 %) |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 4,545 | 0 | 392,674 | 388.1 K to 392.7 K (+1.17 %) |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 13,636 | 0 | 388,129 | 374.5 K to 388.1 K (+3.64 %) |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 22,727 | 0 | 374,493 | 351.8 K to 374.5 K (+6.46 %) |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | WILSON ROBERT N | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 20,000 | |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | WILSON ROBERT N | Director | Grant | A | 0.00 | 6,818 | 0 | 760,936 | 754.1 K to 760.9 K (+0.90 %) |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | FRIEDMAN PAUL A | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 20,000 | |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | FRIEDMAN PAUL A | Director | Grant | A | 0.00 | 1,136 | 0 | 6,817 | 5.7 K to 6.8 K (+20.00 %) |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | FRIEDMAN PAUL A | Director | Grant | A | 0.00 | 5,681 | 0 | 5,681 | 0 to 5.7 K |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 20,000 | |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Grant | A | 0.00 | 2,272 | 0 | 49,392 | 47.1 K to 49.4 K (+4.82 %) |
Jul 06 2015 | SNTA | SYNTA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Grant | A | 0.00 | 5,681 | 0 | 47,120 | 41.4 K to 47.1 K (+13.71 %) |
Jul 02 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 20,000 | |
Jul 02 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Grant | A | 0.00 | 4,545 | 0 | 3,092,677 | 3.1 M to 3.1 M (+0.15 %) |
Jul 02 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Grant | A | 0.00 | 4,545 | 0 | 3,088,132 | 3.1 M to 3.1 M (+0.15 %) |
Jul 02 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Grant | A | 0.00 | 22,727 | 0 | 3,083,587 | 3.1 M to 3.1 M (+0.74 %) |
Jul 02 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | J | 0.00 | 354,146 | 0 | 120,854 | 475 K to 120.9 K (-74.56 %) |
Jul 02 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | J | 0.00 | 475,000 | 0 | 0 | 475 K to 0 (-100.00 %) |
Jul 02 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | J | 0.00 | 475,000 | 0 | 0 | 475 K to 0 (-100.00 %) |
Jul 02 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | J | 0.00 | 475,000 | 0 | 0 | 475 K to 0 (-100.00 %) |
Jul 02 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | J | 0.00 | 125,000 | 0 | 0 | 125 K to 0 (-100.00 %) |
Jul 02 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | J | 0.00 | 125,000 | 0 | 0 | 125 K to 0 (-100.00 %) |
Jul 02 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Sell | J | 0.00 | 250,000 | 0 | 0 | 250 K to 0 (-100.00 %) |
Jul 02 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Buy | J | 0.00 | 2,279,146 | 0 | 2,279,146 | 0 to 2.3 M |
Jun 08 2015 | SNTA | SYNTA PHARMACEUTIC ... | Schor Chen | President and CEO | Option Exercise | A | 2.40 | 500,000 | 1,200,000 | 500,000 | |
Jun 08 2015 | SNTA | SYNTA PHARMACEUTIC ... | Schor Chen | President and CEO | Grant | A | 0.00 | 150,000 | 0 | 300,000 | 150 K to 300 K (+100.00 %) |
Apr 08 2015 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Buy | P | 1.75 | 6,857,143 | 12,000,000 | 15,278,610 | 8.4 M to 15.3 M (+81.42 %) |
Apr 08 2015 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Buy | P | 1.75 | 350,000 | 612,500 | 3,173,383 | 2.8 M to 3.2 M (+12.40 %) |
Apr 08 2015 | SNTA | SYNTA PHARMACEUTIC ... | WILSON ROBERT N | Director | Buy | P | 1.75 | 50,000 | 87,500 | 754,118 | 704.1 K to 754.1 K (+7.10 %) |
Mar 04 2015 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | SVP, Gen. Counsel | Option Exercise | A | 2.38 | 100,000 | 238,000 | 100,000 | |
Mar 04 2015 | SNTA | SYNTA PHARMACEUTIC ... | McMahon Arthur | SVP, Human Resource ... | Option Exercise | A | 2.38 | 126,768 | 301,708 | 126,768 | |
Mar 04 2015 | SNTA | SYNTA PHARMACEUTIC ... | Vukovic Vojo | SVP, Chief Medical ... | Option Exercise | A | 2.38 | 173,280 | 412,406 | 173,280 | |
Mar 04 2015 | SNTA | SYNTA PHARMACEUTIC ... | Whitaker Anne Clem | President and CEO | Option Exercise | A | 2.38 | 100,000 | 238,000 | 100,000 | |
Dec 10 2014 | SNTA | SYNTA PHARMACEUTIC ... | Schor Chen | Executive VP and CO ... | Option Exercise | A | 2.85 | 450,000 | 1,282,500 | 450,000 | |
Dec 10 2014 | SNTA | SYNTA PHARMACEUTIC ... | Schor Chen | Executive VP and CO ... | Grant | A | 0.00 | 150,000 | 0 | 150,000 | 0 to 150 K |
Dec 10 2014 | SNTA | SYNTA PHARMACEUTIC ... | Schneebaum Marc R | SVP and CFO | Option Exercise | A | 2.85 | 225,000 | 641,250 | 225,000 | |
Dec 10 2014 | SNTA | SYNTA PHARMACEUTIC ... | Schneebaum Marc R | SVP and CFO | Grant | A | 0.00 | 75,000 | 0 | 75,000 | 0 to 75 K |
Oct 01 2014 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Buy | P | 3.08 | 300,000 | 923,130 | 8,421,467 | 8.1 M to 8.4 M (+3.69 %) |
Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Option Exercise | A | 4.10 | 10,000 | 41,000 | 10,000 | |
Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Grant | A | 0.00 | 1,219 | 0 | 3,060,860 | 3.1 M to 3.1 M (+0.04 %) |
Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Grant | A | 0.00 | 1,219 | 0 | 3,059,641 | 3.1 M to 3.1 M (+0.04 %) |
Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Grant | A | 0.00 | 9,756 | 0 | 3,058,422 | 3 M to 3.1 M (+0.32 %) |
Sep 04 2014 | SNTA | SYNTA PHARMACEUTIC ... | Whitaker Anne Clem | President and CEO | Option Exercise | A | 4.00 | 250,000 | 1,000,000 | 250,000 | |
Sep 04 2014 | SNTA | SYNTA PHARMACEUTIC ... | Whitaker Anne Clem | President and CEO | Option Exercise | A | 4.00 | 500,000 | 2,000,000 | 500,000 | |
Sep 04 2014 | SNTA | SYNTA PHARMACEUTIC ... | Whitaker Anne Clem | President and CEO | Grant | A | 0.00 | 500,000 | 0 | 500,000 | 0 to 500 K |
Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | FRIEDMAN PAUL A | Director | Option Exercise | A | 4.10 | 10,000 | 41,000 | 10,000 | |
Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Option Exercise | A | 4.10 | 4,500 | 18,450 | 4,500 | |
Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Option Exercise | A | 4.10 | 10,000 | 41,000 | 10,000 | |
Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 1,219 | 0 | 351,766 | 350.5 K to 351.8 K (+0.35 %) |
Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 1,219 | 0 | 350,547 | 349.3 K to 350.5 K (+0.35 %) |
Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 2,439 | 0 | 349,328 | 346.9 K to 349.3 K (+0.70 %) |
Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 4,878 | 0 | 346,889 | 342 K to 346.9 K (+1.43 %) |
Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 9,756 | 0 | 342,011 | 332.3 K to 342 K (+2.94 %) |
Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 4.10 | 10,000 | 41,000 | 10,000 | |
Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Grant | A | 0.00 | 4,878 | 0 | 41,439 | 36.6 K to 41.4 K (+13.34 %) |
Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | KUFE DONALD W | Director | Option Exercise | A | 4.10 | 10,000 | 41,000 | 10,000 | |
Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | WILSON ROBERT N | Director | Option Exercise | A | 4.10 | 10,000 | 41,000 | 10,000 | |
Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | WILSON ROBERT N | Director | Grant | A | 0.00 | 2,439 | 0 | 704,118 | 701.7 K to 704.1 K (+0.35 %) |
Apr 14 2014 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Buy | P | 4.01 | 1,250,000 | 5,012,500 | 8,121,467 | 6.9 M to 8.1 M (+18.19 %) |
Mar 05 2014 | SNTA | SYNTA PHARMACEUTIC ... | McMahon Arthur | SVP, People Operati ... | Option Exercise | A | 6.15 | 115,000 | 707,250 | 115,000 | |
Mar 05 2014 | SNTA | SYNTA PHARMACEUTIC ... | Vukovic Vojo | SVP, Chief Medical ... | Option Exercise | A | 6.15 | 141,211 | 868,448 | 141,211 | |
Mar 05 2014 | SNTA | SYNTA PHARMACEUTIC ... | Rieder Wendy E | VP, IP and Legal, G ... | Option Exercise | A | 6.15 | 66,512 | 409,049 | 66,512 | |
Mar 05 2014 | SNTA | SYNTA PHARMACEUTIC ... | Ehrlich Keith S | VP, Fin. and Admin. ... | Option Exercise | A | 6.15 | 66,985 | 411,958 | 66,985 | |
Mar 05 2014 | SNTA | SYNTA PHARMACEUTIC ... | FRIEDMAN PAUL A | Director | Option Exercise | A | 6.15 | 20,000 | 123,000 | 20,000 | |
Dec 20 2013 | SNTA | SYNTA PHARMACEUTIC ... | Bernitz Steven B | SVP, Corporate Deve ... | Option Exercise | A | 4.34 | 150,000 | 651,000 | 150,000 | |
Dec 20 2013 | SNTA | SYNTA PHARMACEUTIC ... | Bernitz Steven B | SVP, Corporate Deve ... | Grant | A | 0.00 | 25,000 | 3 | 25,000 | 0 to 25 K |
Nov 15 2013 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 3.75 | 20,000 | 75,000 | 2,053,135 | 2 M to 2.1 M (+0.98 %) |
Nov 15 2013 | SNTA | SYNTA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Buy | P | 3.75 | 13,333 | 49,999 | 36,561 | 23.2 K to 36.6 K (+57.40 %) |
Nov 15 2013 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Buy | P | 3.75 | 150,000 | 562,500 | 2,823,383 | 2.7 M to 2.8 M (+5.61 %) |
Nov 15 2013 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Buy | P | 3.75 | 3,400,000 | 12,750,000 | 7,649,803 | 4.2 M to 7.6 M (+80.00 %) |
Nov 15 2013 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Buy | P | 3.75 | 1,600,000 | 6,000,000 | 1,600,000 | 0 to 1.6 M |
Jul 03 2013 | SNTA | SYNTA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 5.00 | 10,000 | 50,000 | 10,000 | |
Jul 03 2013 | SNTA | SYNTA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Grant | A | 0.00 | 4,000 | 0 | 23,228 | 19.2 K to 23.2 K (+20.80 %) |
Jul 03 2013 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Option Exercise | A | 5.00 | 10,000 | 50,000 | 10,000 | |
Jul 03 2013 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Grant | A | 0.00 | 1,000 | 0 | 6,180,330 | 6.2 M to 6.2 M (+0.02 %) |
Jul 03 2013 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Grant | A | 0.00 | 1,000 | 0 | 6,179,330 | 6.2 M to 6.2 M (+0.02 %) |
Jul 03 2013 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Grant | A | 0.00 | 8,000 | 0 | 6,178,330 | 6.2 M to 6.2 M (+0.13 %) |
Jul 03 2013 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Option Exercise | A | 5.00 | 4,500 | 22,500 | 4,500 | |
Jul 03 2013 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Option Exercise | A | 5.00 | 10,000 | 50,000 | 10,000 | |
Jul 03 2013 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 1,000 | 0 | 332,255 | 331.3 K to 332.3 K (+0.30 %) |
Jul 03 2013 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 1,000 | 0 | 331,255 | 330.3 K to 331.3 K (+0.30 %) |
Jul 03 2013 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 2,000 | 0 | 330,255 | 328.3 K to 330.3 K (+0.61 %) |
Jul 03 2013 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 4,000 | 0 | 328,255 | 324.3 K to 328.3 K (+1.23 %) |
Jul 03 2013 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 8,000 | 0 | 324,255 | 316.3 K to 324.3 K (+2.53 %) |
Jul 03 2013 | SNTA | SYNTA PHARMACEUTIC ... | WILSON ROBERT N | Director | Option Exercise | A | 5.00 | 10,000 | 50,000 | 10,000 | |
Jul 03 2013 | SNTA | SYNTA PHARMACEUTIC ... | WILSON ROBERT N | Director | Grant | A | 0.00 | 2,000 | 0 | 701,679 | 699.7 K to 701.7 K (+0.29 %) |
Jul 03 2013 | SNTA | SYNTA PHARMACEUTIC ... | KUFE DONALD W | Director | Option Exercise | A | 5.00 | 10,000 | 50,000 | 10,000 | |
Jul 03 2013 | SNTA | SYNTA PHARMACEUTIC ... | KUFE DONALD W | Director | Grant | A | 0.00 | 8,000 | 0 | 25,748 | 17.7 K to 25.7 K (+45.08 %) |
Jul 01 2013 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Buy | P | 4.71 | 150,000 | 706,515 | 3,100,000 | 3 M to 3.1 M (+5.08 %) |
Jul 01 2013 | SNTA | SYNTA PHARMACEUTIC ... | Bahcall Safi R | President and CEO | Buy | P | 5.03 | 10,000 | 50,299 | 2,033,135 | 2 M to 2 M (+0.49 %) |
Jun 27 2013 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Buy | P | 4.65 | 300,000 | 1,395,930 | 2,950,000 | 2.7 M to 3 M (+11.32 %) |
Jun 27 2013 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Buy | P | 4.35 | 200,000 | 869,460 | 2,650,000 | 2.5 M to 2.7 M (+8.16 %) |
Jun 25 2013 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Buy | P | 4.23 | 50,000 | 211,520 | 2,250,000 | 2.2 M to 2.3 M (+2.27 %) |
Jun 25 2013 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Buy | P | 4.43 | 200,000 | 885,920 | 2,450,000 | 2.3 M to 2.5 M (+8.89 %) |